22Nov/18
CAR-T cells Armored with Mini PD-1 Antibody Exhibit Stronger Anti-Tumor Efficacy
Recently, scientists from the Memorial Sloan Kettering (MSK) Cancer Center announced that they have established the latest engineered cells with powerful efficiency, which combine chimeric antigen receptor (CAR) -T cells and checkpointRead More…